Problems arising from the generalising of treatment efficacy from clinical trials in Alzheimer's disease. Mistaking statistical significance as clinical significance

Clinical Drug Investigation

Volumn 19, Issue 1, 2000, Pages 33-41

  Becker, Robert ^a,c   Markwell, Stephen ^b  

^a BOSTON UNIVERSITY   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Box 2311C ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRIFONATE;

ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033979004     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019010-00005     Document Type: Article

References (23)

1. Sackett DL. The competing objectives of randomized trials. N Engl J Med 1994; 303: 1059-60
2. Leon AC, Marzuk PM, Portera L. More reliable outcome measures can reduce sample size requirements. Arch Gen Psychiatry 1995; 52: 867-71
3. Pablos-Mendez A, Barr RG, Shea S. Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 1998; 279: 222-5
4. Davis KL, Thal LJ, Gamzu ER, et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992; 327: 1253-9
5. Becker R, Colliver J, Elble R, et al. Effects of metifonate, a long acting cholinesterase inhibitor in Alzheimer Disease: Report of an Open Trial. Drug Dev Res 1990; 9: 425-34
6. Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multi-center, randomized, double-blind, placebo-controlled trial. Dementia 1996; 7: 293-303
7. Rogers SL, Farlow MD, Doody RS, et al. A 24-week, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998; 50: 136-44
8. Folstein MF, Folstein SE, McHugh PR. Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98
9. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer disease. Am J Psychiatry 1984; 141: 1356-64
10. Becker RE, Colliver JA, Markwell SJ, et al. Double-blind, placebo-controlled study of metrifonate, an acetylcholines-terase inhibitor, for Alzheimer disease. Alzheimer Dis Assoc Disord 1996; 10: 124-31
11. Becker RE, Colliver JA, Markwell SJ, et al. A six month study of the effects of metrifonate on cognitive decline in Alzheimer's Disease. Alzheimers Dis Assoc Disord 1998; 12: 54-7
12. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, NJ: Erlhaum, 1988
13. Brennan RL. Elements of generalizability theory. Iowa City, 1A: American College Testing Publications, 1983
14. Anastasi A. Psychological testing. 6th ed. New York: Macmillan Publishing Company, 1988
15. Hayes WL. Statistics for psychologists. New York: Holt, Rinehart and Winston, 1963
16. Cohen J. A power primer. Psychol Bull 1992; 112: 155-9
17. Becker R. Issues in the uses of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychopharmacol 1998; 1: 82-7
18. Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271: 985-91
19. HEW. Peripheral and Central Nervous System Drugs Advisory Committee Meeting; 1989 Jul 7; Rockville MD: Department of Health and Human Services. Public Health Service, Food and Drug Administration, 1989: 227
20. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Clin Consult Psychol 1991; 59: 12-9
21. Tukey JW. Exploratory data analysis. New York: Appleton-Century-Crofts, 1977
22. Nunnally JC. Psychometric theory. New York: McGraw-Hill, 1967 Lindgren BR, Wielinski CL, Finkelstein SM, et al. Contrasting clinical and statistical significance within the research setting. Pediatr Pulmonol 1993; 16: 336-40
23. Nunnally JC. Psychometric theory. New York: McGraw-Hill, 1967 Lindgren BR, Wielinski CL, Finkelstein SM, et al. Contrasting clinical and statistical significance within the research setting. Pediatr Pulmonol 1993; 16: 336-40